-
VANCOUVER, British Columbia, Nov. 28, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the 鈥淐ompany鈥� or 鈥淩akovina Therapeutics鈥�) a biopharmaceutical company committed to advancing...
-
VANCOUVER, British Columbia, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the 鈥淐ompany鈥� or 鈥淩akovina Therapeutics鈥�) a biopharmaceutical company committed to advancing...
-
VANCOUVER, British Columbia, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (鈥淩akovina鈥� or the 鈥淐ompany鈥�), a biopharmaceutical company committed to advancing new cancer...
-
VANCOUVER, British Columbia, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (鈥淩akovina鈥� or the 鈥淐ompany鈥�), a biopharmaceutical company committed to advancing new cancer...
-
VANCOUVER, British Columbia, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (鈥淩akovina鈥� or the 鈥淐ompany鈥�), a biopharmaceutical company committed to advancing new cancer...
-
VANCOUVER, British Columbia, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) a biopharmaceutical company committed to advancing new cancer therapies based on novel...
-
VANCOUVER, British Columbia, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) a biopharmaceutical company committed to advancing new cancer therapies based on novel...
-
All dollar amounts reflected in Canadian dollars unless otherwise stated. VANCOUVER, British Columbia, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the 鈥淐ompany鈥�) a...
-
VANCOUVER, British Columbia, July 26, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (the 鈥淐ompany鈥�), a biopharmaceutical company committed to advancing new cancer therapies based...
-
All dollar amounts reflected in Canadian dollars unless otherwise stated. VANCOUVER, British Columbia, July 22, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (the 鈥淐ompany鈥�), a...